CABERFIX-0.25 Tablet
Cabergoline 0.25 mg Tablet – PCD Pharma Franchise, Manufacturers & Wholesale Suppliers
| Composition | Cabergoline 0.25 mg |
|---|---|
| Dosage Form | Tablet |
| Pack Type | Alu-Alu Blister |
| Pack Size | 10 x 1 x 4 Tablets |
| MRP | ₹ 2200 |
| Therapy | Gynaecology / Endocrinology – Hyperprolactinaemia — Ergot-derived dopamine D2 receptor agonist |
| Storage | Store below 30 °C in a dry place, protected from light and moisture. Keep in the original pack and out of reach of children. |
📱 WhatsApp Enquiry📞 Call: +919041677932
For chemists, distributors, medical representatives and doctors: CABERFIX-0.25 (Cabergoline 0.25 mg Tablet) is available from Trumac Healthcare on a PCD franchise with monopoly rights for your district, and as wholesale stock for licensed distributors. No franchise fee; first order from ₹25,000 – work out your margin with the PTR / PTS calculator (PTR and PTS full form; most medicines carry 5% GST).
About CABERFIX-0.25 Tablet
CABERFIX-0.25 Tablet is Trumac Healthcare’s cabergoline 0.25 mg tablet in a 10 x 1 x 4 Alu-Alu pack (MRP ₹2200), made for Trumac at WHO-GMP certified partner units. It is a prescription-only medicine for use under a gynaecologist’s or endocrinologist’s supervision.
Cabergoline is a long-acting dopamine agonist that lowers prolactin secretion from the pituitary gland. It is used for hyperprolactinaemic disorders – including those caused by prolactin-secreting pituitary adenomas – and, where approved, to prevent or suppress breast milk production for medical reasons. Its long action allows dosing once or twice a week.
Cabergoline is a regular prescription in gynaecology and endocrinology practice, which makes CABERFIX-0.25 a valuable specialist product for gynae PCD franchise partners and distributors.
Looking up another Trumac medicine? See what every Trumac Healthcare brand is used for – A–Z in English and Hindi: Trumac Healthcare tablet uses. Take medicines only as your doctor prescribes.
Indications
- Hyperprolactinaemic disorders, idiopathic or due to prolactin-secreting pituitary adenomas (micro- and macroadenomas), and associated amenorrhoea, galactorrhoea and hypogonadism
- Inhibition or suppression of physiological lactation for medical reasons, where approved and prescribed
Mechanism of Action
Cabergoline is an ergot-derived agonist with high affinity for dopamine D2 receptors on the prolactin-secreting cells (lactotrophs) of the anterior pituitary. Dopamine is the natural inhibitor of prolactin release, so stimulating these receptors lowers prolactin levels and can shrink prolactin-secreting tumours. Its long half-life (about 63–69 hours) allows once- or twice-weekly dosing. It is extensively metabolised in the liver.
Dosage & Administration
Only as prescribed. Hyperprolactinaemia: usually started at 0.5 mg a week (as one dose or 0.25 mg twice a week), increased gradually at monthly intervals according to serum prolactin, commonly to 1 mg a week (range 0.25–2 mg a week). Lactation inhibition: a single dose or short course as prescribed. Take with food to reduce nausea. Monitor serum prolactin; before starting long-term treatment, assess the heart (echocardiography), lungs and kidneys, and repeat echocardiography periodically during treatment. Check blood pressure in the first days, especially after delivery.
Side Effects
Common: nausea, headache, dizziness, low blood pressure on standing, tiredness, abdominal pain, constipation and breast pain. Less common: low mood, flushing, hot flushes. Serious with long-term or high-dose use: fibrosis of heart valves (valvulopathy), lungs, pleura or retroperitoneum. Impulse-control disorders (pathological gambling, increased libido, compulsive spending or eating), sudden sleep onset and psychiatric effects have been reported.
Contraindications & Precautions
Do not use: in hypersensitivity to cabergoline or other ergot derivatives; with a history of pulmonary, pericardial or retroperitoneal fibrotic disorders; with evidence of cardiac valvulopathy (for long-term treatment); in uncontrolled high blood pressure or pre-eclampsia/eclampsia; with a history of puerperal psychosis; in severe hepatic insufficiency. Precautions: heart disease, Raynaud's syndrome, peptic ulcer, psychiatric illness and liver impairment. Interactions: avoid dopamine antagonists (antipsychotics, metoclopramide), macrolide antibiotics (raise levels) and other ergot alkaloids; take care with antihypertensives. Can cause sudden sleepiness – avoid driving if affected. Pregnancy should be excluded before starting; effective non-hormonal contraception is advised during treatment if pregnancy is not desired, and pregnancy tests are advised if a period is missed. Breastfeeding: cabergoline suppresses milk production and should not be used by women who intend to breastfeed.
Storage
Store below 30 °C in a dry place, protected from light and moisture. Keep in the original pack and out of reach of children.
CABERFIX-0.25 Tablet is available for monopoly-based PCD pharma franchise across India and for third-party manufacturing under your brand. WHO-GMP certified, with full visual-aid and promotional support. Become a Trumac franchise partner →
From Trumac Healthcare, a pharma franchise company in India, available on a monopoly basis – see the gynaecology products franchise product list (PDF). See our full PCD franchise tablets range. Comparing companies? See the compare gynae PCD companies. No franchise fee; minimum first order ₹25,000 – cost and documents.
Other strengths and forms in the CABERFIX range: Caberfix-0.5.
Frequently Asked Questions
What is CABERFIX-0.25 used for?
It contains cabergoline 0.25 mg and is used for high prolactin levels (hyperprolactinaemia), including prolactin-secreting pituitary tumours, and where approved to stop breast milk production, as prescribed.
How often is cabergoline taken?
Because it is long-acting, cabergoline is usually taken once or twice a week, as prescribed – not every day.
Why is a heart scan advised with cabergoline?
Long-term use has been linked to thickening and leaking of heart valves, so echocardiography is advised before and periodically during long-term treatment.
Can cabergoline be used while breastfeeding?
No, it stops milk production. Women who plan to breastfeed should not take it.
Who manufactures cabergoline 0.25 mg tablets in India for PCD franchise?
CABERFIX-0.25 is made for Trumac Healthcare at WHO-GMP certified partner units and supplied across India. Trumac has been a PCD pharma franchise company since 2007 with 4000+ franchise partners.
Is cabergoline 0.25 mg tablets available on a PCD pharma franchise on monopoly basis?
Yes. CABERFIX-0.25 is offered on PCD franchise with monopoly rights for your district, with no franchise fee or deposit. The minimum first order is ₹25,000.
Can distributors and wholesalers buy cabergoline 0.25 mg tablets in bulk?
Yes. Licensed distributors, wholesalers and chemists can buy CABERFIX-0.25 on wholesale – message us on WhatsApp at +91 90416 77932 for net rates. Orders are usually dispatched the same day the payment reflects.
What is the pack size and MRP of CABERFIX-0.25?
10 x 1 x 4 tablets (4 tablets per Alu-Alu strip), MRP ₹2200 as per the current product list.
How do I start a cabergoline tablet PCD franchise?
Share your drug licence and district on WhatsApp (+91 90416 77932). We check district availability and send the product list and rates; stock is dispatched after the first order is confirmed.
